Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-20 4:9:1 am | Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer | GlobeNewsWire |
| 2024-03-13 4:5:0 am | Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting | GlobeNewswire |
| 2024-03-12 4:5:0 am | Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days | GlobeNewswire |
| 2024-03-06 1:25:0 pm | Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024 | GlobeNewswire |
| 2024-02-29 1:5:0 pm | Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024 | GlobeNewswire |
| 2024-02-07 1:5:0 pm | Vigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology Conference | GlobeNewswire |
| 2024-01-03 1:30:0 pm | Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information